))
Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
Manage episode 505889749 series 3689489
Content provided by KDIGO Communications. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KDIGO Communications or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. David Jayne (Addenbrooke's Hospital, United Kingdom) discuss the roles of various agents in the induction and maintenance treatment of ANCA- associated vasculitis. They will explore the use of rituximab and complement inhibition in treating ANCA-associated vasculitis. This episode will address the gaps in knowledge and ongoing research in the field of ANCA-associated vasculitis. This episode is supported by Amgen.
…
continue reading
28 episodes
Share
